mRNA is cool but hardly affordable so long as it's tech in the hands of private pharmaceutical companies.
definitely a promising avenue for future vaccine tech, but has some pretty considerable logistical and economical problems, too.
it’s an epidemiological commonplace that poorer populations, communities, regions, etc, are impacted far more than richer ones. a vaccine tech that requires -70 degree transport temps or whatever it is does not bode particularly well for the majority of the world’s population who aren’t in well-developed nations, and who are by default staring down a much longer barrel when it comes to endemic or pandemic crises. but that’s by the by.
Last edited by uziq (2021-01-21 04:03:29)